ÂÜÀòÂÒÂ×

Glenn Kanner is a seasoned professional in the medical device and pharmaceutical industries, currently serving as VP of Program Management at Invea Therapeutics, where efforts focus on AI-initiated clinical drug development programs. As a partner at Kanner Development, Glenn specializes in new product development, regulatory compliance, and risk management, providing expert guidance in design controls and regulatory strategies for combination products. Previous leadership roles include Senior Director positions at Angion and Radius Health, Inc., as well as the founding of Nubel Medical, Inc. Notable experience spans multiple companies, including Den-Mat Holdings and Medtronic, with a consistent emphasis on innovative product design and cross-functional collaboration. Glenn holds an MBA from the University of Massachusetts and degrees in Mechanical Engineering and Chemistry from The University of Akron, alongside dental training from The Ohio State University.